MBRX
Moleculin Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.71
+5.09%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.60x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.23x
Liquidity & coverage
- Current ratio
- 0.94x
- Quick ratio
- 0.94x
- Cash ratio
- 0.78x
- Interest coverage
- -370.18x
- EBITDA / interest
- -387.31x
- Working capital
- -$590.0K
Cash & dividend
- FCF / debt
- -86.84x
- Cash flow / debt
- -86.84x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026